Manher Joshi serves as Executive at Atara Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Manher Joshi has executed 6 insider transactions totaling $16.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 21, 2026 involved receiving (via award) 4,700 shares valued at $0.
Manher Joshi currently holds 4,700 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Manher Joshi has been a net seller of ATRA stock. They have purchased $0 and sold $16.3K worth of shares.
Manher Joshi's most recent insider trade was on Jan 21, 2026, when they sold 4,700 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 10, 2025 | SLNO | $0 | Award | 16,071 | $N/A | Discretionary |
| Nov 16, 2023 | ATRA | $4.8K | Sale | 12,287 | $0.39 | Discretionary |
| Aug 16, 2023 | ATRA | $6.2K | Sale | 3,773 | $1.65 | Discretionary |
| Aug 16, 2023 | ATRA | $5.3K | Sale | 3,202 | $1.65 | Discretionary |